Dent Neurologic

new masking policy – masks are now optional

DENTNeuro_White

PADOVA

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson’s Disease

Inclusion Criteria

  • Parkinson’s Disease
  • **other criteria will apply

For more information, call Heather MacNamara at 716-819-4117 or email hmacnamara@dentinstitute.com. You can also visit https://forpatients.roche.com/en/trials/neurodegenerative-disorder/pd/a-study-to-evaluate-the-efficacy-and-safety-of-intraven-35605.html

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top